Clinical trial registry record

Mediterranean Diet, Circuit Resistance Training, Empagliflozin in Elderly With Type 2 Diabetes: a Study Protocol

A registered PHASE4 study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Completed.
Evidence
Registered phase 4 study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated September 4, 2025.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT03560375
Last registry update
September 4, 2025
Status
Completed
Phase
Phase 4
Sponsor
Tel-Aviv Sourasky Medical Center
Enrollment
100
Countries
Israel
Match confidence
100%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered PHASE4 study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase 4
Study design
RANDOMIZED · PARALLEL · TREATMENT · SINGLE
Evidence population
Human clinical study registration
Participants
100
Population
ALL · 65 Years
Duration
2018-05-09 to 2021-02-10
Intervention
Circuit resistance training (CRT); Vegeterranean diet (V-Med diet); Empagliflozin 10 MG
Comparator
Not reported
Outcomes measured
A composite of metabolic and functional indices — After 10 weeks (for all 3 arms) and after 20 weeks (for diet and drug…; Change in fasting plasma glucose — After 10 weeks (for all 3 arms) and after 20 weeks (for diet and drug arms only); Change in sarcopenia — After 10 weeks (for all 3 arms) and after 20 weeks (for diet and drug arms only); Change in strength — After 10 weeks (for all 3 arms) and after 20 weeks (for diet and drug arms only); Relative lean mass change — after 10 weeks (for all 3 arms) and after 20 weeks (for diet and drug arms only)
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase 4A trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 100% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Mediterranean diet · 100%Title contains controlled term: mediterranean diet. Abstract contains controlled term: mediterranean diet. Title supplies longevity context: elderly. Study type is explicitly identified as INTERVENTIONAL.
  • Resistance training · 100%Title contains controlled term: resistance training. Abstract contains controlled term: resistance training. Source terminology contains: resistance training. Title supplies longevity context: elderly. Study type is explicitly identified as INTERVENTIONAL.

Automated source check 100% · update recency 65%. These figures help sort records; they are not medical ratings.

mediterranean dietresistance training
Open primary sourceExport JSON